FR6764M - - Google Patents

Info

Publication number
FR6764M
FR6764M FR98531A FR98531A FR6764M FR 6764 M FR6764 M FR 6764M FR 98531 A FR98531 A FR 98531A FR 98531 A FR98531 A FR 98531A FR 6764 M FR6764 M FR 6764M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR98531A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR6764M publication Critical patent/FR6764M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR98531A 1966-03-12 1967-03-13 Expired FR6764M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6603256A NL6603256A (fr) 1966-03-12 1966-03-12

Publications (1)

Publication Number Publication Date
FR6764M true FR6764M (fr) 1969-03-10

Family

ID=19795968

Family Applications (1)

Application Number Title Priority Date Filing Date
FR98531A Expired FR6764M (fr) 1966-03-12 1967-03-13

Country Status (13)

Country Link
US (1) US3534041A (fr)
BE (1) BE695304A (fr)
BR (1) BR6787719D0 (fr)
CH (1) CH501647A (fr)
DE (2) DE1695556C3 (fr)
DK (1) DK124824B (fr)
ES (1) ES337526A1 (fr)
FI (1) FI51694C (fr)
FR (1) FR6764M (fr)
GB (1) GB1173783A (fr)
GR (1) GR37262B (fr)
NL (2) NL6603256A (fr)
SE (1) SE331999B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714148A (en) * 1968-10-15 1973-01-30 Sumitomo Chemical Co Process for preparing dibenzazocine derivatives and salts thereof
NL179906C (nl) * 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
NL7610942A (nl) * 1976-10-02 1978-04-04 Akzo Nv Werkwijze voor het bereiden van 1,4-diazepine derivaten.
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
GB2091247B (en) * 1980-12-31 1984-07-18 Beecham Group Ltd Pentacyclic compounds processes for their preparation and their use
EP0088575B1 (fr) * 1982-03-05 1986-12-30 Beecham Group Plc Composés pentacycliques
EP0090552A3 (fr) * 1982-03-27 1984-04-25 Beecham Group Plc Composés pentacycliques
EP0126343A1 (fr) * 1983-05-18 1984-11-28 Beecham Group Plc Traitement de la diarrhée
DE3472678D1 (de) * 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
EP0379483B1 (fr) * 1987-04-10 1999-12-29 Monash University DERIVES AZEPINO DE 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f] PYRAZINO- 1,2-a]
US5189161A (en) * 1989-08-07 1993-02-23 Hoechst Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
EP0475482B1 (fr) 1990-09-13 1994-10-05 Akzo Nobel N.V. Compositions chimiques solides stabilisées
US5859012A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP1017695A4 (fr) * 1997-09-26 2002-01-16 Univ Monash Resolution de composes optiquement actifs
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US6723445B2 (en) 2001-12-31 2004-04-20 Canon Kabushiki Kaisha Organic light-emitting devices
MXPA06002789A (es) 2003-09-12 2006-06-14 Pfizer Combinaciones que comprenden ligandos alfa-2-delta.
MX2007006695A (es) 2004-12-03 2007-08-14 Schering Corp Piperazinas sustituidas como antagonistas de cb1.
AU2006269231A1 (en) 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
EP2314289A1 (fr) 2005-10-31 2011-04-27 Braincells, Inc. Modulation de la neurogenese dont la médiation est assurée par récepteur gaba
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
BRPI0706623A2 (pt) 2006-01-18 2011-04-12 Schering Corp moduladores de receptor canabinóide
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (fr) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenese induite par le recepteur 5ht
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (fr) 2006-09-08 2008-03-13 Braincells, Inc. Combinaisons contenant un dérivé de 4-acylaminopyridine
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (fr) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation de la neurogenèse par des ligands mélatoninergiques
EP2125017A2 (fr) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation de la neurogenèse en utilisant du modafinil
CA2692268A1 (fr) 2007-06-28 2009-01-08 Intervet International B.V. Piperazines a substitution servant d'antagonistes des recepteurs cb1
WO2009128058A1 (fr) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Produits psycho-pharmaceutiques
EP2309858A4 (fr) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd Compositions et procédés de traitement de troubles inflammatoires
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004975A (en) * 1961-10-17 Cochs
US3005789A (en) * 1955-10-11 1961-10-24 Gen Aniline & Film Corp Drier composition
US3151116A (en) * 1961-11-03 1964-09-29 Ciba Geigy Corp Certain 2-aza-indolo [2, 3-alpha] quinolizine compounds
US3328396A (en) * 1961-11-09 1967-06-27 Sterling Drug Inc 3, 8-di-substituted-3, 8-diazabicyclo [3.2.1] octanes
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3317524A (en) * 1965-02-04 1967-05-02 American Home Prod Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes

Also Published As

Publication number Publication date
GR37262B (el) 1969-05-10
CH501647A (de) 1971-01-15
FI51694C (fi) 1977-03-10
ES337526A1 (es) 1968-03-01
BR6787719D0 (pt) 1973-12-26
DE1795836C2 (de) 1978-07-20
DK124824B (da) 1972-11-27
DE1695556A1 (de) 1972-01-20
BE695304A (fr) 1967-09-11
DE1695556C3 (de) 1981-06-25
SE331999B (fr) 1971-01-25
GB1173783A (en) 1969-12-10
NL129434C (fr)
US3534041A (en) 1970-10-13
DE1795836B1 (de) 1977-11-24
DE1695556B2 (de) 1980-10-30
NL6603256A (fr) 1967-09-13
FI51694B (fr) 1976-11-30

Similar Documents

Publication Publication Date Title
AT281852B (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU414526B2 (fr)
AU433222B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU1144366A (fr)
AU6703465A (fr)
AU612166A (fr)
AU1111066A (fr)
AU5895065A (fr)
AU218666A (fr)
BE447356A (fr)
BE618801A (fr)
AU2390066A (fr)
AU407778B2 (fr)
AU415780B2 (fr)
BE666282A (fr)
AU411645B2 (fr)
AU6852465A (fr)
AU855865A (fr)
AU92366A (fr)